The Global Experience in Addressing Cervical Cancer
June 30, 2015
Cervical cancer is caused by the human papillomavirus (HPV), an infectious disease that far too often strikes young women in the prime of their lives. On April 24, CSIS convened a day-long conference, “The Global Experience in Addressing Cervical Cancer,” to answer two major questions: what has been achieved since the introduction of the HPV vaccine in 2006, and what is needed next to address the unfinished agenda? Panelists discussed the major achievements and challenges in expanding access to methods to prevent, diagnose, and treat cervical cancer, with a special focus on the role of the HPV vaccine. This is a summary of those discussions.